It is not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease
Mounjaro is NOT suitable for: Patients who are pregnant, breastfeeding, or planning for pregnancy Personal or family history of medullary thyroid carcinoma Have Multiple Endocrine Neoplasia Syndrome Type 2 (MEN2) Serious allergy to Tirzepatide or its active ingredients History of pancreatitis, gallbladder disease, or severe digestive problems At Da Vinci Clinic, Malaysias Leading Skin Clinic and Aesthetic Clinic, we provide every patient with a comprehensive full-body assessment before determining whether Mounjaro is suitable for them
Whilst menstrual irregularities are not listed as recognised adverse reactions in the MHRA-approved Summary of Product Characteristics, some women report changes to their menstrual cycle during treatment
Se produce a partir de precursores que son otros dos aminocidos: la lisina y la metionina
El uso prolongado debe evaluarse peridicamente segn la evolucin clnica